Sökning: onr:"swepub:oai:lup.lub.lu.se:8fd256a0-1d9f-4432-b36b-8b5014b1cbd5" > Testosterone Levels...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03229naa a2200397 4500 | |
001 | oai:lup.lub.lu.se:8fd256a0-1d9f-4432-b36b-8b5014b1cbd5 | |
003 | SwePub | |
008 | 240112s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/8fd256a0-1d9f-4432-b36b-8b5014b1cbd52 URI |
024 | 7 | a https://doi.org/10.1089/jpm.2022.03812 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Ferreira, Diana H.u University of Wollongong4 aut |
245 | 1 0 | a Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness : An Exploratory Study |
264 | 1 | b Mary Ann Liebert Inc,c 2023 |
300 | a 4 s. | |
520 | a Background: The intermediate- and long-term effects of regular low-dose sustained-release (SR) morphine on the testosterone levels of people with persistent breathlessness are unknown. Methods: Exploratory analysis of a randomized controlled trial of the effects of regular SR morphine (0/8/16/24 mg every 24 hours) for persistent breathlessness associated with chronic obstructive pulmonary disease. Total testosterone was measured at baseline and at cessation (greater than or equal to three months on stable medication). Results: Among 20 participants (9 males; median treatment duration between measurements 169 days [IQR 162-175]), only 3 had substantial declines in testosterone levels during the study (morphine 8, 16, 24 mg groups). All three had worsening illness at the time of the second assessment. There was no apparent relationship between change in testosterone, morphine dose, and change in breathlessness. Conclusions: Substantial declines in testosterone were uncommon and were not apparently related to changes in morphine dose or breathlessness, but they were possibly related with worsening illness. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Lungmedicin och allergi0 (SwePub)302192 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Respiratory Medicine and Allergy0 (SwePub)302192 hsv//eng |
653 | a persistent breathlessness | |
653 | a placebo | |
653 | a randomized controlled trial | |
653 | a safety | |
653 | a sustained-release morphine | |
653 | a testosterone | |
700 | 1 | a Ekstrom, Magnusu Lund University,Lunds universitet,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-mue |
700 | 1 | a Fazekas, Belindau University of Technology Sydney4 aut |
700 | 1 | a Currow, David C.u University of Wollongong4 aut |
710 | 2 | a University of Wollongongb Lungmedicin, allergologi och palliativ medicin4 org |
773 | 0 | t Journal of Palliative Medicined : Mary Ann Liebert Incg 26:3, s. 402-405q 26:3<402-405x 1096-6218x 1557-7740 |
856 | 4 | u http://dx.doi.org/10.1089/jpm.2022.0381y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/8fd256a0-1d9f-4432-b36b-8b5014b1cbd5 |
856 | 4 8 | u https://doi.org/10.1089/jpm.2022.0381 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy